



Kisspeptin-10 is the 10 amino acid C-terminal fragment of the KISS1 gene product, also known as metastin 45-54, and it is the shortest kisspeptin sequence with full intrinsic activity. It works through GPR54, a receptor whose transcripts colocalize with GnRH neurons in the mouse hypothalamus. The genetic evidence is unusually clean: GPR54 is required in mice and in humans for pulsatile LH and FSH secretion to begin at puberty, and kisspeptin that triggers robust LH and FSH release in wild-type mice does nothing in gpr54 knockout mice. In sheep, central administration released GnRH directly into cerebrospinal fluid with a parallel rise in serum LH. That position at the top of the reproductive axis is why it is studied as a tool for probing hypothalamic control rather than pituitary or gonadal signaling.
Structured specifications and handling data
Technical specifications
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2C63H83N17O14Stability and handling
The reproductive axis has a known chain of command: hypothalamic GnRH neurons release GnRH in pulses, the pituitary answers with LH and FSH, and the gonads respond to those. Kisspeptin sits one step above the top of that chain. GPR54 transcripts colocalize with GnRH neurons, and in gpr54 knockout mice the GnRH neurons themselves look anatomically normal and project to the median eminence, so the hypogonadism in those animals is a signaling failure rather than a wiring one. Kisspeptin given to those knockouts does nothing, which attributes the whole effect to GPR54.
The direct measurement came in sheep, where intracerebroventricular kisspeptin produced a clear release of GnRH into cerebrospinal fluid with a parallel rise in serum LH. In men, intravenous kisspeptin-10 raised serum LH in a dose-dependent way, with the largest response at 1 microgram per kilogram and a smaller response at 3, and deconvolution analysis during a lower-rate infusion showed LH pulse frequency rising from about 0.7 to 1.0 pulses per hour alongside larger secretory bursts. The frequency result matters because pulse frequency, not just total output, is what the downstream pituitary reads.
The response is not uniform. In healthy women in the follicular phase, kisspeptin-10 failed to move gonadotropins even at the highest amounts tested, while the same peptide worked in men and in women during the preovulatory phase. Any study design has to account for that sexual dimorphism and for cycle stage. Kisspeptin-10 analogs with amino acid substitutions have also been developed as antagonists, and those blocked the post-castration LH rise in sheep, rats and mice, which is how kisspeptin neurons were implicated in steroid negative feedback.
Published studies and concise summaries for research review.
AI-generated summary of this research paper below.
Concise answers about laboratory context, handling, and documentation for this compound.
Laboratory compliance notice
All compounds sold by Validated Peptides are intended for in-vitro laboratory research only.
These materials are not approved by the FDA for human or animal use and are not intended for diagnostic, therapeutic, or clinical applications.
Purchasers are responsible for compliant handling, storage, and use within an appropriate laboratory environment.